Marie Wood on the Potential of Aspirin to Reduce Breast Density

Article

Marie Wood, MD, medical oncologist, University of Vermont, discusses the correlation between aspirin use and lower breast density.

Marie Wood, MD, medical oncologist, University of Vermont, discusses the correlation between aspirin use and lower breast density.

Using mammographic breast density as a biomarker, Wood and fellow researchers conducted an assessment of 26,000 women to examine the relationship between density and aspirin use.

Results showed that women with lower breast density were 1.73 times more likely to take aspirin than women with high breast density. The relationship was also found to be strong in younger women and African American women.

Wood says that although the findings are preliminary, a dosage of at least 300 mg per day seems to correlate with lower breast density.

Related Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Alison Tray, of Hartford Healthcare, discusses her team's research on a multidisciplinary team approach to manage the cancer drug shortage
Related Content
© 2024 MJH Life Sciences

All rights reserved.